248 related articles for article (PubMed ID: 21792899)
1. Toll-like receptor genes and their association with colon and rectal cancer development and prognosis.
Slattery ML; Herrick JS; Bondurant KL; Wolff RK
Int J Cancer; 2012 Jun; 130(12):2974-80. PubMed ID: 21792899
[TBL] [Abstract][Full Text] [Related]
2. Interleukin genes and associations with colon and rectal cancer risk and overall survival.
Bondurant KL; Lundgreen A; Herrick JS; Kadlubar S; Wolff RK; Slattery ML
Int J Cancer; 2013 Feb; 132(4):905-15. PubMed ID: 22674296
[TBL] [Abstract][Full Text] [Related]
3. Genetic variation in selenoprotein genes, lifestyle, and risk of colon and rectal cancer.
Slattery ML; Lundgreen A; Welbourn B; Corcoran C; Wolff RK
PLoS One; 2012; 7(5):e37312. PubMed ID: 22615972
[TBL] [Abstract][Full Text] [Related]
4. MAP kinase genes and colon and rectal cancer.
Slattery ML; Lundgreen A; Wolff RK
Carcinogenesis; 2012 Dec; 33(12):2398-408. PubMed ID: 23027623
[TBL] [Abstract][Full Text] [Related]
5. COX-1 (PTGS1) and COX-2 (PTGS2) polymorphisms, NSAID interactions, and risk of colon and rectal cancers in two independent populations.
Makar KW; Poole EM; Resler AJ; Seufert B; Curtin K; Kleinstein SE; Duggan D; Kulmacz RJ; Hsu L; Whitton J; Carlson CS; Rimorin CF; Caan BJ; Baron JA; Potter JD; Slattery ML; Ulrich CM
Cancer Causes Control; 2013 Dec; 24(12):2059-75. PubMed ID: 24022467
[TBL] [Abstract][Full Text] [Related]
6. Variations within Toll-like receptor (TLR) and TLR signaling pathway-related genes and their synergistic effects on the risk of Guillain-Barré syndrome.
Dutta D; Nagappa M; Sreekumaran Nair BV; Das SK; Wahatule R; Sinha S; Vasanthapuram R; Taly AB; Debnath M
J Peripher Nerv Syst; 2022 Jun; 27(2):131-143. PubMed ID: 35138004
[TBL] [Abstract][Full Text] [Related]
7. Involvement of Toll-like receptors in cervical cancer susceptibility among Tunisian women.
Zidi S; Verdi H; Yilmaz-Yalcin Y; Yazici AC; Gazouani E; Mezlini A; Atac FB; Yacoubi-Loueslati B
Bull Cancer; 2014 Oct; 101(10):E31-5. PubMed ID: 25373689
[TBL] [Abstract][Full Text] [Related]
8. Gene polymorphisms of TLR2 and TLR3 in HBV clearance and HBV-related hepatocellular carcinoma in a Chinese male population.
Chen D; Xie W; Lu Y; Su S; Nong L; Jia Y; Liu Y; Zhou W; Wang H; Tan A
Int J Biol Markers; 2017 May; 32(2):e195-e201. PubMed ID: 28009434
[TBL] [Abstract][Full Text] [Related]
9. PPARgamma and colon and rectal cancer: associations with specific tumor mutations, aspirin, ibuprofen and insulin-related genes (United States).
Slattery ML; Curtin K; Wolff R; Ma KN; Sweeney C; Murtaugh M; Potter JD; Levin TR; Samowitz W
Cancer Causes Control; 2006 Apr; 17(3):239-49. PubMed ID: 16489531
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Toll-Like Receptors 2/3/4/9 Gene Polymorphisms in Cervical Cancer Evolution.
Zidi S; Sghaier I; Gazouani E; Mezlini A; Yacoubi-Loueslati B
Pathol Oncol Res; 2016 Apr; 22(2):323-30. PubMed ID: 26548749
[TBL] [Abstract][Full Text] [Related]
11. TERT's role in colorectal carcinogenesis.
Pellatt AJ; Wolff RK; Herrick J; Lundgreen A; Slattery ML
Mol Carcinog; 2013 Jul; 52(7):507-13. PubMed ID: 22351525
[TBL] [Abstract][Full Text] [Related]
12. Single-nucleotide polymorphisms in genes encoding toll-like receptor -2, -3, -4, and -9 in case-control study with breast cancer.
Etokebe GE; Knezević J; Petricević B; Pavelić J; Vrbanec D; Dembić Z
Genet Test Mol Biomarkers; 2009 Dec; 13(6):729-34. PubMed ID: 19810822
[TBL] [Abstract][Full Text] [Related]
13.
Jabłońska A; Zagrapan B; Neumayer C; Klinger M; Eilenberg W; Nanobachvili J; Paradowska E; Brostjan C; Huk I
J Immunol; 2020 Jun; 204(11):2900-2909. PubMed ID: 32284335
[TBL] [Abstract][Full Text] [Related]
14. Toll-like-Receptor Gene Polymorphisms in Tunisian Endemic Pemphigus Foliaceus.
Abida O; Bahloul E; Elloumi N; Toumi A; Tahri S; Ben Jmaa M; Fakhfakh R; Mahfoudh N; Turki H; Masmoudi H
Biomed Res Int; 2020; 2020():6541761. PubMed ID: 33204706
[TBL] [Abstract][Full Text] [Related]
15. Association of TLR2, TLR3, TLR4 and CD14 genes polymorphisms with oral cancer risk and survival.
Zeljic K; Supic G; Jovic N; Kozomara R; Brankovic-Magic M; Obrenovic M; Magic Z
Oral Dis; 2014 May; 20(4):416-24. PubMed ID: 23796347
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms of the TLR2 and TLR4 genes are associated with risk of gastric cancer in a Brazilian population.
de Oliveira JG; Silva AE
World J Gastroenterol; 2012 Mar; 18(11):1235-42. PubMed ID: 22468087
[TBL] [Abstract][Full Text] [Related]
17. Genetic variants in the regulation region of TLR4 reduce the gastric cancer susceptibility.
Li Z; Gao H; Liu Y; Wu H; Li W; Xing Y; Zhang Z; Zhang X
Gene; 2021 Jan; 767():145181. PubMed ID: 33007372
[TBL] [Abstract][Full Text] [Related]
18. Clinical Implication of Toll-Like Receptors (TLR2 and TLR4) in Acute Myeloid Leukemia Patients.
Aref S; Abd Elmaksoud ASM; Abd Elaziz S; Mabed M; Ayed M
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3177-3183. PubMed ID: 33247673
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of Toll-like receptor (TLR) 2 and TLR4 in the colonic mucosa of children with inflammatory bowel disease.
Szebeni B; Veres G; Dezsõfi A; Rusai K; Vannay A; Mraz M; Majorova E; Arató A
Clin Exp Immunol; 2008 Jan; 151(1):34-41. PubMed ID: 17991289
[TBL] [Abstract][Full Text] [Related]
20. JAK/STAT/SOCS-signaling pathway and colon and rectal cancer.
Slattery ML; Lundgreen A; Kadlubar SA; Bondurant KL; Wolff RK
Mol Carcinog; 2013 Feb; 52(2):155-66. PubMed ID: 22121102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
